58489-52-4

Upstream product

• 94357-76-3 3-(3,4-dimethoxyphenyl)pyrrolidine-2,5-dione 
• 74-88-4 methyl iodide 

Downstream Products

• 99897-25-3 N-methyl-3-(3,4-dimethoxyphenyl)-3-<3-(trimethylsilylmethyl)but-3-en-1-yl>succinimide 
• 21104-34-7 N-methyl-3a-<3,4-(dimethoxy)phenyl>-2,3,3a,4,5,6,7,7a-octahydroindole-2,6-dione 
• 99897-26-4 1-methyl-4-(3,4-dimethoxyphenyl)-4-<3-(trimethylsilylmethyl)but-3-en-1-yl>-5-hydroxy-2-pyrrolidone 
• 99897-28-6 7-aza-7-methyl-8-oxo-1-(3,4-dimethoxyphenyl)-4-methylenbicyclo<3.4.0>nonane 
• 120238-25-7 3-(3,4-dimethoxyphenyl)-1-methyl-4-(methylene)pyrrolidine-2,5-dione 
• 120238-28-0 3-(3,4-dimethoxyphenyl)-1,4-dimethyl-3-pyrroline-2,5-dione 
• 120238-23-5 3-(3,4-dimethoxyphenyl)-4-ethoxalyl-1-(methyl)pyrrolidine-2,5-dione 

Relevant academic research and scientific papers

Synthesis of cis-4-methyl-3-phenylpyrrolidines as potential dopaminergic agonists

cis-3-(3,4-Dihydroxyphenyl)-4-methyl-l-(n-propyl)pyrrolidine (23) was synthesized and evaluated for dopaminergic activity. The synthesis of 23 involved selective 4-acylation of the 3-phenylpyrrolidine-2,5-dione 15 and cis-addition of hydrogen to a 4-methy